Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Korro Bio (KRRO) Accounts Payables (2019 - 2025)

Historic Accounts Payables for Korro Bio (KRRO) over the last 7 years, with Q3 2025 value amounting to $2.3 million.

  • Korro Bio's Accounts Payables fell 6134.45% to $2.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.3 million, marking a year-over-year decrease of 6134.45%. This contributed to the annual value of $4.0 million for FY2024, which is 4516.48% down from last year.
  • As of Q3 2025, Korro Bio's Accounts Payables stood at $2.3 million, which was down 6134.45% from $5.2 million recorded in Q2 2025.
  • Korro Bio's 5-year Accounts Payables high stood at $7.3 million for Q4 2023, and its period low was $338000.0 during Q3 2023.
  • For the 5-year period, Korro Bio's Accounts Payables averaged around $3.8 million, with its median value being $3.9 million (2021).
  • In the last 5 years, Korro Bio's Accounts Payables crashed by 9156.9% in 2023 and then skyrocketed by 166035.5% in 2024.
  • Korro Bio's Accounts Payables (Quarter) stood at $2.7 million in 2021, then dropped by 5.2% to $2.6 million in 2022, then surged by 179.46% to $7.3 million in 2023, then crashed by 45.16% to $4.0 million in 2024, then plummeted by 42.38% to $2.3 million in 2025.
  • Its Accounts Payables stands at $2.3 million for Q3 2025, versus $5.2 million for Q2 2025 and $4.2 million for Q1 2025.